ENTRADA THERAPEUTICS

Serial Number 97673254
Registration 7538588
700

Registration Progress

Application Filed
Nov 11, 2022
Under Examination
Jan 2, 2024
Approved for Publication
Nov 7, 2023
Published for Opposition
Nov 7, 2023
Registered
Oct 15, 2024

Trademark Image

ENTRADA THERAPEUTICS

Basic Information

Serial Number
97673254
Registration Number
7538588
Filing Date
November 11, 2022
Registration Date
October 15, 2024
Published for Opposition
November 7, 2023
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Oct 15, 2024
Registration
Registered
Classes
005 042

Rights Holder

Entrada Therapeutics, Inc.

03
Address
One Design Center Pl, Suite 17-500
Boston, MA 02210

Ownership History

Entrada Therapeutics, Inc.

Original Applicant
03
Boston, MA

Entrada Therapeutics, Inc.

Owner at Publication
03
Boston, MA

Entrada Therapeutics, Inc.

Original Registrant
03
Boston, MA

Legal Representation

Attorney
Stephanie H. Bald

USPTO Deadlines

Next Deadline
1731 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20241015)
Due Date
October 15, 2030
Grace Period Ends
April 15, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

36 events
Date Code Type Description Documents
Oct 15, 2024 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Oct 15, 2024 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Sep 9, 2024 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Sep 9, 2024 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Jul 30, 2024 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jul 30, 2024 GNRT O NON-FINAL ACTION E-MAILED Loading...
Jul 30, 2024 CNRT W SU - NON-FINAL ACTION - WRITTEN Loading...
Jul 10, 2024 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
May 29, 2024 IUAF S USE AMENDMENT FILED Loading...
May 29, 2024 IUAF S USE AMENDMENT FILED Loading...
May 29, 2024 IUAF S USE AMENDMENT FILED Loading...
Jul 7, 2024 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
May 30, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
May 29, 2024 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
May 29, 2024 EX1G S SOU EXTENSION 1 GRANTED Loading...
May 29, 2024 EXT1 S SOU EXTENSION 1 FILED Loading...
May 29, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jan 2, 2024 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Nov 7, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Nov 7, 2023 PUBO A PUBLISHED FOR OPPOSITION Loading...
Oct 18, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Oct 3, 2023 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Oct 2, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Oct 2, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Oct 2, 2023 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Aug 28, 2023 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Aug 28, 2023 GNRT F NON-FINAL ACTION E-MAILED Loading...
Aug 28, 2023 CNRT R NON-FINAL ACTION WRITTEN Loading...
Aug 25, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
Jul 24, 2023 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Jul 24, 2023 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Jul 24, 2023 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Jul 24, 2023 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Jul 24, 2023 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Dec 2, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Nov 15, 2022 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
House mark for a line of pharmaceuticals, but not including pharmaceuticals intended to treat multiple sclerosis or related diseases or conditions related to multiple sclerosis, all of the foregoing specifically excluding pharmaceutical preparations for the treatment of cancer
First Use Anywhere: Jun 14, 2022
First Use in Commerce: Jun 14, 2022
Class 042
Pharmaceutical research and development services
First Use Anywhere: 20230200
First Use in Commerce: 20230200

Additional Information

Translation
The English translation of ENTRADA in the mark is entry.

Classification

International Classes
005 042

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"THERAPEUTICS"